4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-005165
Options or other derivatives
- Executive Chairman disposed of 208,600 shares (other)
- Executive Chairman acquired 9,968 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reich Samuel J Executive Chairman | 2023-02-28 | Other disposition · Warrants | −208,600 | 0 | I | ||
| Reich Samuel J Executive Chairman | 2023-02-28 | Other acquisition · Warrants | +9,968 | 9,968 | D | ||
Loading xslF345X03/rdgdoc.xml…